| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 66/07/02 | 91/08/26 | 李志文 | 白友烺 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.65(Q2) | 20.5 | 1.88 | 3.05% |
| 實收資本額 | 已發行普通股 | ||
| 1,677,220,220 | 167,722,022 | ||
| 主要經營業務 | |||
| 西藥,抗生素,化妝品之製造加工買賣醫療器材之製造加工買賣,藥品原料之合成,中藥批發,農業服務業,其他工商服務業(菌種育種之研發) | |||
| 公司網址 | |||
| sinphar.com | |||
杏輝(1734) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 227,103 | 240,083 | 1% | -5.4% | 1,950,221 | 1,817,424 | 7.3% |
| 2023/07 | 224,786 | 193,219 | 0.8% | 16.3% | 1,723,118 | 1,577,341 | 9.2% |
| 2023/06 | 222,942 | 239,595 | -15.8% | -6.9% | 1,498,332 | 1,384,122 | 8.3% |
| 2023/05 | 264,870 | 257,980 | 10.6% | 2.7% | 1,275,390 | 1,144,527 | 11.4% |
| 2023/04 | 239,580 | 217,214 | -27.4% | 10.3% | 1,010,520 | 886,547 | 14% |
| 2023/03 | 329,968 | 262,316 | 55.4% | 25.8% | 770,940 | 669,333 | 15.2% |
| 2023/02 | 212,309 | 166,743 | -7.2% | 27.3% | 440,972 | 407,017 | 8.3% |
| 2023/01 | 228,663 | 240,274 | -8.6% | -4.8% | 228,663 | 240,274 | -4.8% |
| 2022/12 | 250,087 | 226,318 | -2.8% | 10.5% | 2,856,376 | 2,433,644 | 17.4% |
| 2022/11 | 257,236 | 217,091 | 1% | 18.5% | 2,606,289 | 2,207,326 | 18.1% |
| 2022/10 | 254,765 | 197,558 | -8% | 29% | 2,349,053 | 1,990,235 | 18% |
| 2022/09 | 276,864 | 211,669 | 15.3% | 30.8% | 2,094,288 | 1,792,677 | 16.8% |
| 2022/08 | 240,083 | 192,807 | 24.3% | 24.5% | 1,817,424 | 1,581,008 | 14.9% |
| 2022/07 | 193,219 | 163,286 | -19.4% | 18.3% | 1,577,341 | 1,388,201 | 13.6% |
| 2022/06 | 239,595 | 200,857 | -7.1% | 19.3% | 1,384,122 | 1,224,915 | 13% |
| 2022/05 | 257,980 | 202,915 | 18.8% | 27.1% | 1,144,527 | 1,024,058 | 11.8% |
| 2022/04 | 217,214 | 202,986 | -17.2% | 7% | 886,547 | 821,143 | 8% |
| 2022/03 | 262,316 | 209,831 | 57.3% | 25% | 669,333 | 618,157 | 8.3% |
| 2022/02 | 166,743 | 187,459 | -30.6% | -11.1% | 407,017 | 408,326 | -0.3% |
| 2022/01 | 240,274 | 220,867 | 6.2% | 8.8% | 240,274 | 220,867 | 8.8% |
| 2021/12 | 226,318 | 173,050 | 4.3% | 30.8% | 2,433,644 | 2,388,452 | 1.9% |
| 2021/11 | 217,091 | 185,698 | 9.9% | 16.9% | 2,207,326 | 2,215,402 | -0.4% |
| 2021/10 | 197,558 | 180,624 | -6.7% | 9.4% | 1,990,235 | 2,029,704 | -1.9% |
| 2021/09 | 211,669 | 237,151 | 9.8% | -10.7% | 1,792,677 | 1,849,080 | -3% |
| 2021/08 | 192,807 | 204,066 | 18.1% | -5.5% | 1,581,008 | 1,611,929 | -1.9% |
| 2021/07 | 163,286 | 200,095 | -18.7% | -18.4% | 1,388,201 | 1,407,863 | -1.4% |
| 2021/06 | 200,857 | 177,598 | -1% | 13.1% | 1,224,915 | 1,207,768 | 1.4% |
| 2021/05 | 202,915 | 207,854 | 0% | -2.4% | 1,024,058 | 1,030,170 | -0.6% |
| 2021/04 | 202,986 | 197,144 | -3.3% | 3% | 821,143 | 822,316 | -0.1% |
| 2021/03 | 209,831 | 248,999 | 11.9% | -15.7% | 618,157 | 625,172 | -1.1% |
| 2021/02 | 187,459 | 214,339 | -15.1% | -12.5% | 408,326 | 376,173 | 8.5% |
| 2021/01 | 220,867 | 161,834 | 26.9% | 36.5% | 220,867 | 161,834 | 36.5% |
| 2020/12 | 174,029 | 250,306 | -6.3% | -30.5% | 2,389,431 | 2,393,577 | -0.2% |
| 2020/11 | 185,698 | 229,946 | 2.8% | -19.2% | 2,215,402 | 2,143,271 | 3.4% |
| 2020/10 | 180,624 | 190,643 | -23.8% | -5.3% | 2,029,704 | 1,913,325 | 6.1% |
| 2020/09 | 237,151 | 189,657 | 16.2% | 25% | 1,849,080 | 1,722,682 | 7.3% |
亞諾法(4133) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 3.49% | -1.03% | 2020Q3 | 29.45% | 8.66% |
| 2023Q1 | -11.63% | -0.93% | 2020Q2 | 3.41% | -0.07% |
| 2022Q4 | 6.28% | 2.77% | 2020Q1 | -3.31% | -2.09% |
| 2022Q3 | -1.30% | -3.47% | 2019Q4 | 4.73% | 1.74% |
| 2022Q2 | 3.74% | -4.88% | 2019Q3 | -4.76% | -1.81% |
| 2022Q1 | 2.43% | -3.34% | 2019Q2 | -4.60% | -2.51% |
| 2021Q4 | -16.50% | -4.77% | 2019Q1 | 12.81% | -0.19% |
| 2021Q3 | -6.62% | -3.60% | 2018Q4 | -9.33% | -3.45% |
| 2021Q2 | 8.68% | 4.45% | 2018Q3 | -7.08% | -3.38% |
| 2021Q1 | -4.31% | 3.16% | 2018Q2 | 4.46% | -1.74% |
| 2020Q4 | -10.66% | 3.67% | 2018Q1 | -1.89% | -2.17% |
評論0